FindTrial
Sign In

use of Rasanjanadi anjana and haridra seka in eyelids infection

CLINICAL STUDY TO EVALUATE THE EFFICACY OF RASAANJANADI ANJAN AND HARIDRA SEKA IN PRAKLINNA VARTMA(Anterior Blepharitis)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025879
Enrollment
40
Registered
2020-06-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

Intervention1: Rasaanjanadi anjana(ointment) along with haridra seka: 20 patient will be given Dose of 3 mg of rasaanjanadi anjana(ointment) + Haridra Seka (Local Application) for 15 days Control Inte

Sponsors

Gurukul campus UAU Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: person having symptoms of itching, discharge, heaviness in lids, burning sensation, pricking sensation, gluing of cilia, scaling of eyelashes, falling of eyelashes and bulbar congestion.

Exclusion criteria

Exclusion criteria: corneal ulcer, entropion, ectropion, Posterior blephritis, dandruff of scalp and eyebrows, uncorrected refractive error, skin disorders, diabetes, hypertension and tumor

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Rasanjanadi Anjana and Haridra Seka in Praklinnvartma(Anterior Blephritis)Timepoint: 4 month—

Secondary

MeasureTime frame
To evaluate the efficacy of Rasanjanadi Anjana and Haridra Seka in Praklinnvartma(Anterior Blephritis) along with dietry advice.Timepoint: 4 Months—

Countries

India

Contacts

Public ContactDr Abhilasha

Gurukul campus UAU

docaditi24@gmail.com9719353123

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026